Compare SILO & BNZI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SILO | BNZI |
|---|---|---|
| Founded | 2010 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Apparel | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0M | 9.6M |
| IPO Year | N/A | N/A |
| Metric | SILO | BNZI |
|---|---|---|
| Price | $0.41 | $1.22 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $23.00 |
| AVG Volume (30 Days) | 132.6K | ★ 499.4K |
| Earning Date | 11-13-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $72,102.00 | ★ $10,650,176.00 |
| Revenue This Year | $1.86 | $223.24 |
| Revenue Next Year | N/A | $31.42 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 147.06 |
| 52 Week Low | $0.36 | $1.09 |
| 52 Week High | $3.37 | $27.00 |
| Indicator | SILO | BNZI |
|---|---|---|
| Relative Strength Index (RSI) | 36.44 | 39.28 |
| Support Level | $0.42 | $1.11 |
| Resistance Level | $0.46 | $1.37 |
| Average True Range (ATR) | 0.02 | 0.11 |
| MACD | 0.00 | 0.04 |
| Stochastic Oscillator | 2.22 | 33.85 |
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.
Banzai International Inc is a marketing technology (MarTech) company that produces data-driven marketing and sales solutions for businesses of all sizes. Its mission is to help its customers accomplish their mission by enabling marketing, sales and customer engagement outcomes. The company has two reportable operating segments, Banzai Operating and OpenReel. The company's segments deliver SaaS tools that leverage data, analytics, and AI to provide marketing and sales solutions for business of all size. it derives maximum revenue from Banzai Operating segment. Geographically, it operates in Americas, Europe, Middle East and Africa (EMEA), and Asia Pacific.